DIGESTIVE HEALTH
IBS Blood Test UK: Which Tests Rule Out Something Serious — and What to Keep Monitoring
You've been told it's IBS. The GP ran a couple of tests, said everything looked fine, and handed you a leaflet about the low-FODMAP diet. Six months later you're still alternating between constipation and urgent dashes to the bathroom, and you can't shake the feeling that something was missed.
You're not imagining it. Irritable bowel syndrome affects an estimated 10–20% of the UK population, making it one of the most common conditions in primary care. But IBS is a diagnosis of exclusion — it means your symptoms match a recognised pattern and other conditions have been ruled out. The question is whether they were actually ruled out thoroughly enough.
NICE guideline CG61 (updated as NG61) sets out the minimum blood tests that should happen before an IBS diagnosis is made: full blood count, ESR or CRP, coeliac serology, and — for diarrhoea-predominant symptoms — faecal calprotectin to screen for inflammatory bowel disease. In practice, many patients receive an IBS label after just one or two of these tests, missing treatable conditions such as subclinical hypothyroidism, iron-deficiency anaemia, vitamin B12 deficiency, and even early coeliac disease.
This guide covers the 10 biomarkers most relevant to IBS investigation and monitoring, explains what each one reveals, shows you the gap between NHS standard ranges and the optimal levels where gut symptoms often resolve, and maps out the result patterns that point to specific treatable causes.
1. Why blood tests matter when you have IBS
IBS does not have a blood test that says “positive.” Instead, blood tests serve two critical purposes in IBS care:
Exclusion. The diagnostic criteria for IBS (Rome IV) require that symptoms are not better explained by another condition. At least eight conditions produce symptoms indistinguishable from IBS — coeliac disease, inflammatory bowel disease, thyroid dysfunction, bile acid malabsorption, microscopic colitis, small intestinal bacterial overgrowth, pancreatic insufficiency, and colorectal cancer. Each leaves a measurable trace in blood work.
Monitoring. Even when IBS is the correct diagnosis, nutritional deficiencies accumulate over time — particularly in patients following restrictive diets such as low-FODMAP. Iron, B12, folate, and vitamin D levels can silently fall, causing fatigue, brain fog, and mood changes that are blamed on IBS rather than on the deficiency itself.
A single comprehensive blood panel at diagnosis, repeated every 6–12 months, catches both problems: conditions that should never have been labelled IBS, and nutritional gaps that develop in people who genuinely have it.
2. The NICE NG61 investigation pathway
NICE clinical guideline CG61 (2008, updated 2017 as NG61) remains the standard reference for IBS diagnosis in the UK. It defines IBS as abdominal pain or discomfort relieved by defecation, or associated with altered bowel frequency or stool form, persisting for at least six months, in the absence of red-flag features.
Before confirming IBS, NICE recommends the following minimum investigations:
| Test | Purpose | NICE reference |
|---|---|---|
| Full blood count (FBC) | Screen for anaemia, infection, inflammation | NG61 1.2.1 |
| ESR or CRP | Inflammatory marker — elevated in IBD, infection | NG61 1.2.1 |
| Coeliac serology (tTG-IgA) | Screen for coeliac disease | NG61 1.2.1 |
| Faecal calprotectin | Distinguish IBS from IBD (diarrhoea-predominant) | DG11 |
This is a sensible minimum but it is exactly that — a minimum. It does not check thyroid function (a known cause of both constipation and diarrhoea), ferritin (which can be depleted long before haemoglobin drops), or the nutritional markers that deteriorate in patients on restrictive diets.
A comprehensive IBS investigation adds six further biomarkers to the NICE minimum, giving a much clearer picture of whether IBS is the right diagnosis and whether your gut is absorbing nutrients properly.
3. 10 biomarkers for IBS investigation
These are the markers most likely to reveal a treatable cause behind IBS symptoms, or to flag nutritional decline in someone with established IBS.
1. tTG-IgA (tissue transglutaminase antibody)
The primary screening test for coeliac disease. NICE NG20 estimates that 1 in 100 people in the UK have coeliac disease, but most are undiagnosed. Many present with IBS-type symptoms for years before testing. A positive tTG-IgA triggers a referral for duodenal biopsy to confirm the diagnosis. You must be eating gluten regularly (more than one meal per day for at least six weeks) for the test to be reliable.
2. hs-CRP (high-sensitivity C-reactive protein)
A more sensitive inflammation marker than standard CRP. In IBS investigation, hs-CRP helps distinguish functional gut symptoms from inflammatory bowel disease (Crohn's, ulcerative colitis). Values consistently above 5 mg/L warrant further investigation. Values between 1–3 mg/L suggest low-grade systemic inflammation that may be contributing to gut hypersensitivity.
3. Full blood count (FBC)
The FBC reveals anaemia (low haemoglobin), microcytosis (small red cells — iron deficiency), macrocytosis (large red cells — B12 or folate deficiency), and elevated white cell count (infection or inflammation). All of these can co-exist with IBS or point to something else entirely.
4. Ferritin
Iron stores fall long before haemoglobin does. Ferritin below 30 µg/L causes fatigue, restless legs, and brain fog — symptoms often blamed on IBS. In the context of IBS, low ferritin may also indicate malabsorption, particularly if dietary iron intake is adequate. Optimal ferritin for energy is above 50 µg/L; many IBS patients sit in the 15–30 range that the NHS considers “normal.”
5. TSH (thyroid-stimulating hormone)
Thyroid dysfunction directly affects gut motility. Hypothyroidism slows the migrating motor complex (MMC), the wave-like contractions that sweep food residue through the small intestine between meals. A sluggish MMC leads to bacterial overgrowth, fermentation, gas, bloating, and constipation — symptoms identical to IBS-C. Hyperthyroidism accelerates transit, causing diarrhoea that mimics IBS-D. Even TSH in the 3.0–4.5 mIU/L “grey zone” can produce measurable gut symptoms in some patients.
6. FT4 (free thyroxine)
Testing FT4 alongside TSH catches the full picture. A “normal” TSH with a low-normal FT4 can indicate early thyroid dysfunction that is already affecting gut motility. The combination is far more informative than TSH alone — yet the NHS typically tests FT4 only if TSH is already abnormal.
7. Vitamin D
Vitamin D receptors are present throughout the gut lining. Research published in the European Journal of Clinical Nutrition (2016) found that vitamin D deficiency is significantly more common in IBS patients than in the general population. A 2018 systematic review and meta-analysis in the European Journal of Nutrition concluded that vitamin D supplementation improved IBS symptom scores. The SACN threshold of 25 nmol/L prevents rickets but does not represent the level at which gut symptoms resolve. Most functional medicine practitioners target 75–100 nmol/L.
8. Vitamin B12
B12 deficiency causes neurological symptoms (tingling, numbness, cognitive fog) that overlap with the “non-GI” symptoms many IBS patients report. In the context of IBS, low B12 may indicate malabsorption at the terminal ileum (common in Crohn's disease, which can present identically to IBS for years before diagnosis), or it may reflect dietary restriction in patients who have eliminated animal products to manage symptoms.
9. Folate
Folate is absorbed in the proximal small intestine — exactly where coeliac disease causes villous atrophy. Low folate alongside other IBS symptoms increases the index of suspicion for coeliac disease, even if tTG-IgA is borderline. It also depletes in patients on restrictive diets, contributing to fatigue and low mood that compound IBS misery.
10. HbA1c
Blood sugar dysregulation and IBS frequently co-exist. Type 2 diabetes and pre-diabetes cause autonomic neuropathy affecting gut motility (gastroparesis, diarrhoea), and the medications used to treat them (particularly metformin and GLP-1 agonists) are common causes of GI symptoms. HbA1c above 42 mmol/mol indicates pre-diabetes; above 48, diabetes. Both warrant investigation as a primary or contributing cause of gut symptoms.
4. NHS ranges vs optimal ranges for IBS biomarkers
NHS reference ranges define “not diseased.” Optimal ranges define “unlikely to be causing symptoms.” The gap between them is where many IBS patients live — told they're fine while feeling anything but.
| Biomarker | NHS range | Grey zone | Optimal |
|---|---|---|---|
| tTG-IgA | <7 U/mL negative | 7–10 U/mL | <4 U/mL |
| hs-CRP | <5 mg/L | 1–3 mg/L | <1.0 mg/L |
| Ferritin | 15–300 µg/L | 15–50 µg/L | >50 µg/L |
| TSH | 0.27–4.2 mIU/L | 3.0–4.2 mIU/L | 0.5–2.5 mIU/L |
| FT4 | 12–22 pmol/L | 12–14 pmol/L | 15–20 pmol/L |
| Vitamin D | >25 nmol/L | 25–50 nmol/L | 75–100 nmol/L |
| B12 | 180–900 ng/L | 180–300 ng/L | >500 ng/L |
| Folate | >3.0 µg/L | 3–6 µg/L | >12 µg/L |
| HbA1c | <42 mmol/mol | 42–47 mmol/mol | <36 mmol/mol |
| Haemoglobin (FBC) | M: 130–170 g/L F: 120–150 g/L | M: 130–140 F: 120–130 | M: >145 g/L F: >135 g/L |
Sources: NHS, NICE NG145, SACN. Optimal ranges reflect levels at which symptoms are least likely based on published research. They are not diagnostic thresholds.
5. The coeliac connection: why tTG-IgA matters
Coeliac disease is the single most important condition to exclude before accepting an IBS diagnosis. The reason is straightforward: coeliac disease is treatable with a gluten-free diet, and untreated coeliac disease causes progressive intestinal damage, malabsorption, osteoporosis, and an increased risk of intestinal lymphoma.
The overlap between IBS and coeliac disease is substantial. NICE NG20 specifically lists IBS as a presentation that should trigger coeliac testing. Studies suggest that up to 4% of patients diagnosed with IBS actually have coeliac disease — four times the background prevalence.
The gluten caveat. tTG-IgA only works if you are actively eating gluten. If you've already cut out gluten to manage IBS symptoms (as many patients do before being tested), the test will return a false negative. NICE NG20 recommends consuming gluten in at least one meal per day for a minimum of six weeks before testing. This is uncomfortable for patients who feel better without gluten, but it is the only way to get a reliable result.
IgA deficiency. Approximately 1 in 500 people have selective IgA deficiency, which produces a false-negative tTG-IgA. If total IgA is low and coeliac suspicion remains high, your GP should request IgG-based coeliac serology (tTG-IgG or DGP-IgG) as a second-line test.
6. Thyroid and gut motility: the hidden link
The thyroid gland controls the speed at which every system in your body operates, and the gut is no exception. Thyroid hormones regulate the migrating motor complex (MMC) — the cyclical wave of contractions that sweeps undigested food, bacteria, and debris through the small intestine every 90–120 minutes between meals.
Hypothyroidism and IBS-C. When thyroid hormone levels are low, the MMC slows. Food residue sits in the small intestine longer, bacterial fermentation increases, and gas production rises. The result is bloating, abdominal distension, and constipation — a symptom cluster that is clinically indistinguishable from constipation-predominant IBS (IBS-C). Even subclinical hypothyroidism (TSH 4–10, normal FT4) can produce measurable gut transit delays.
Hyperthyroidism and IBS-D. Excess thyroid hormone accelerates gut transit, causing frequent loose stools, urgency, and malabsorption. This pattern mimics diarrhoea-predominant IBS (IBS-D) and is frequently misattributed in younger patients, particularly women in their 20s–40s where both conditions are common.
The testing gap. Most UK GPs do not include thyroid function tests in the standard IBS work-up unless the patient has other thyroid symptoms (weight change, temperature sensitivity, hair thinning). This means a meaningful number of patients are carrying an IBS label when a trial of levothyroxine would resolve their symptoms.
7. IBS vs IBD: how blood tests tell them apart
Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD — Crohn's disease and ulcerative colitis) can produce identical symptoms: abdominal pain, diarrhoea, bloating, urgency, and fatigue. The difference is that IBD involves measurable inflammation and tissue damage, while IBS does not.
Blood tests that help distinguish them:
| Marker | IBS (typical) | IBD (typical) |
|---|---|---|
| hs-CRP | <1.0 mg/L | Often >5 mg/L in flare |
| Faecal calprotectin* | <50 µg/g | Often >250 µg/g |
| FBC (platelets) | Normal | Often elevated (reactive) |
| Ferritin | May be low-normal | Often very low (GI blood loss) |
| Albumin | Normal | May be low (protein-losing enteropathy) |
*Faecal calprotectin is a stool test, not a blood test. It is included here because NICE DG11 recommends it specifically to distinguish IBS from IBD in patients under 40 with diarrhoea-predominant symptoms, and it is the single most useful test for this differentiation.
A normal hs-CRP, normal FBC, and a low faecal calprotectin make IBD very unlikely. If any of these are abnormal, further investigation (colonoscopy, MRI enterography) is warranted before accepting an IBS diagnosis.
8. Five IBS result patterns and what they mean
When all 10 biomarkers are tested together, results tend to cluster into recognisable patterns. Each points toward a specific underlying mechanism that may be driving your symptoms.
Pattern 1: The undiagnosed coeliac
Key markers: tTG-IgA elevated or borderline, ferritin low, folate low, vitamin D low, B12 may be low.
This pattern shows immune-mediated small intestinal damage with downstream malabsorption. The multiple nutrient deficiencies are the telltale signature — the intestinal villi that absorb iron, folate, and fat-soluble vitamins are the exact structures damaged by untreated coeliac disease. Next step: gastroenterology referral for duodenal biopsy. Do not start a gluten-free diet until biopsy is done.
Pattern 2: The thyroid-driven gut
Key markers: TSH elevated (or upper grey zone 3.0–4.2), FT4 low-normal (<15 pmol/L), ferritin may be mildly low, hs-CRP normal.
Gut symptoms driven by slowed motility from thyroid dysfunction. The normal hs-CRP rules out inflammation; the thyroid picture explains the constipation, bloating, and distension. If TSH is above the NHS upper limit, your GP can trial levothyroxine. In the grey zone (3.0–4.2), retest in 3 months and discuss with your GP if symptoms persist.
Pattern 3: The depleted restrictor
Key markers: Ferritin low (<30), vitamin D deficient (<50 nmol/L), B12 low-normal, folate low, tTG-IgA negative, hs-CRP normal, TSH normal.
This person likely does have IBS — the exclusion tests are clear. But the restrictive diet they've adopted to manage symptoms (low-FODMAP, dairy-free, reduced meat) has created nutritional deficiencies that are now adding fatigue, brain fog, and mood problems on top of the original gut symptoms. Targeted supplementation and dietitian support often produce dramatic improvement in quality of life without changing the underlying IBS diagnosis.
Pattern 4: The inflammatory signal
Key markers: hs-CRP elevated (>3 mg/L), ferritin low, FBC shows anaemia or elevated platelets, tTG-IgA negative.
This pattern does not look like IBS — it looks like IBD, infection, or another inflammatory condition that has been labelled as IBS. Elevated hs-CRP with anaemia is a red flag. Next step: faecal calprotectin (if not already done), then gastroenterology referral for colonoscopy if calprotectin is elevated. Do not accept “it's just IBS” with this blood picture.
Pattern 5: The metabolic gut
Key markers: HbA1c elevated (42–47 pre-diabetic, or >48 diabetic), hs-CRP mildly elevated, other markers may be normal.
Dysregulated blood sugar affects the autonomic nerves that control gut motility. Pre-diabetes and early type 2 diabetes can cause gastroparesis (delayed stomach emptying), alternating bowel habits, and postprandial bloating that mimics IBS. Metformin — the first-line treatment for type 2 diabetes — is itself one of the most common drug causes of diarrhoea. If HbA1c is elevated, the gut symptoms may be metabolic, not functional.
9. Red flags: when IBS symptoms need urgent investigation
IBS is common. But some symptoms that look like IBS are not IBS. The following features should prompt urgent investigation — not a blood test, but a same-week GP appointment or A&E attendance as appropriate.
| Red flag | Concern | NICE reference |
|---|---|---|
| Rectal bleeding | Colorectal cancer, IBD | NG12 |
| Unintentional weight loss | Malignancy, IBD, coeliac, hyperthyroidism | NG12 |
| New onset over age 50 | Colorectal cancer | NG12 |
| Iron-deficiency anaemia | GI blood loss (cancer, IBD) | NG24 |
| Persistent vomiting | Obstruction, gastroparesis | NG61 |
| Palpable abdominal mass | Malignancy | NG12 |
| Family history of bowel cancer or IBD | Increased screening threshold | NG12 |
| Night-time symptoms waking you from sleep | IBD (IBS should not wake you) | NG61 |
IBS does not cause weight loss, blood in the stool, fever, or symptoms that wake you at night. If you have any of these alongside your “IBS,” the diagnosis needs revisiting.
10. What the NHS tests vs what Helvy tests
The standard NHS IBS work-up covers 3–4 of the 10 biomarkers listed above. Helvy's Essential and Nutrition panels together cover 9 of 10.
| Biomarker | NHS IBS work-up | Helvy Essential (£129) | Helvy Nutrition (£99) |
|---|---|---|---|
| tTG-IgA | ✓ | ✓ | — |
| hs-CRP | ✓ (standard CRP) | ✓ | — |
| FBC | ✓ | ✓ | — |
| Ferritin | Sometimes | ✓ | — |
| TSH | — | ✓ | — |
| FT4 | — | ✓ | — |
| Vitamin D | — | ✓ | ✓ |
| B12 | — | — | ✓ |
| Folate | — | — | ✓ |
| HbA1c | — | ✓ | — |
The NHS tests the minimum required by NICE guidelines. Helvy tests the minimum plus the markers that most commonly reveal treatable causes hiding behind an IBS label — thyroid function, nutritional status, and metabolic health.
11. Evidence-based next steps by biomarker
Each abnormal result has a specific, evidence-based response. Your GP can action most of these; Helvy flags them in your results dashboard with linked guidance.
| Biomarker | If abnormal | Evidence |
|---|---|---|
| tTG-IgA elevated | Gastroenterology referral for duodenal biopsy. Do not start GF diet until biopsy. | NICE NG20 |
| hs-CRP >5 | Faecal calprotectin. If elevated, colonoscopy referral. | NICE DG11 |
| Ferritin <30 | Iron supplementation (ferrous fumarate 210mg). Investigate cause if male or postmenopausal. | NICE NG24 |
| TSH >4.2 | Repeat in 3 months with FT4 + thyroid antibodies. If persistent, trial levothyroxine. | NICE NG145 |
| Vitamin D <50 | Cholecalciferol (D3) 4,000 IU daily for 3 months, then maintenance 1,000–2,000 IU. | SACN |
| B12 <300 | Oral cyanocobalamin 1,000 µg daily. If <180 or neurological symptoms, IM injections. | NICE NG24 |
| Folate <6 | Folic acid 5mg daily for 4 months. Investigate cause (coeliac, diet, medications). | NHS |
| HbA1c 42–47 | Pre-diabetes. Lifestyle intervention (diet, exercise). Retest 6 months. | NICE NG28 |
| HbA1c >48 | Diabetes diagnosis. GP referral for full metabolic work-up + management. | NICE NG28 |
| FBC: anaemia | Determine type (iron-deficiency, B12/folate, chronic disease). Investigate cause. | NICE NG24 |
12. How and when to test
Timing
Test in the morning before 10am, after an overnight fast of at least 8 hours. HbA1c and ferritin are both affected by recent food intake. Drink water freely — hydration improves sample quality.
The gluten rule
If you want the coeliac screen (tTG-IgA) to be meaningful, you must be eating gluten daily for at least six weeks before testing. If you have already been gluten-free for weeks or months, either do a gluten challenge first or accept that the coeliac result will be unreliable.
Medications
Take regular medications as normal unless your GP advises otherwise. PPIs (omeprazole, lansoprazole) can affect B12 absorption over time — worth noting on your test record. Biotin supplements (common in hair/skin products) can interfere with thyroid assays; stop 48 hours before testing.
Retest frequency
For initial IBS investigation: test once comprehensively. If results are normal and IBS is confirmed: retest nutritional markers (ferritin, B12, folate, vitamin D) every 6–12 months, especially if following a restrictive diet. If any result was borderline: retest the specific marker at 3 months.
13. Which Helvy panel to choose
For IBS investigation and monitoring, we recommend:
Essential Panel (£129) + Nutrition Panel (£99)
Together these cover 9 of the 10 key IBS biomarkers — everything except faecal calprotectin (a stool test your GP should arrange if you have diarrhoea-predominant symptoms). Combined cost: £228.
The Essential panel covers tTG-IgA, hs-CRP, FBC, ferritin, TSH, FT4, HbA1c, and vitamin D. The Nutrition panel adds B12, folate, and additional nutritional markers that track whether your gut is absorbing what you eat.
14. Frequently asked questions
Can a blood test diagnose IBS?
No. There is no blood test that says “positive for IBS.” IBS is a diagnosis of exclusion — blood tests rule out conditions that mimic IBS (coeliac disease, IBD, thyroid dysfunction, anaemia) so that IBS can be diagnosed with confidence once they are cleared.
What blood tests should I ask my GP for if I have IBS?
At minimum: full blood count, CRP or ESR, and coeliac serology (tTG-IgA). These are the NICE NG61 recommendations. For a more complete picture, also ask for TSH, ferritin, vitamin D, B12, folate, and HbA1c. If you have diarrhoea-predominant symptoms, ask for faecal calprotectin.
Is IBS an autoimmune disease?
No. IBS is classified as a functional gastrointestinal disorder, meaning the gut is hypersensitive and dysmotile without structural damage or immune attack. However, coeliac disease (which is autoimmune) and IBD (which involves immune dysregulation) can mimic IBS exactly, which is why screening for both is essential.
Should I get tested during a flare-up or when I feel well?
For exclusion tests (ruling out other conditions), test at any time — coeliac antibodies, thyroid function, and nutritional markers are not significantly affected by whether you're in a flare. For inflammation markers (hs-CRP), testing during a flare can be informative because it may reveal an inflammatory process that is not present between episodes.
Can IBS cause vitamin deficiencies?
IBS itself does not cause malabsorption. However, the restrictive diets many IBS patients adopt (low-FODMAP, dairy-free, reduced-fibre) can lead to deficiencies in iron, B12, folate, calcium, and vitamin D over time. Regular nutritional monitoring is important for anyone on a long-term restricted diet.
How often should I repeat IBS blood tests?
After the initial comprehensive panel: retest nutritional markers (ferritin, B12, folate, vitamin D) every 6–12 months. Retest borderline thyroid or coeliac results at 3 months. If your IBS is well controlled and diet is varied, annual testing is sufficient.
Does a normal calprotectin definitely rule out IBD?
A calprotectin below 50 µg/g makes active IBD very unlikely. However, NICE DG11 notes that calprotectin has a small false-negative rate, particularly for isolated small bowel Crohn's disease. If symptoms persist despite normal calprotectin, discuss further investigation with a gastroenterologist.
Related guides
Bloating Blood Test UK
10 biomarkers behind persistent bloating, coeliac deep-dive, malabsorption cascade
Gut Health Blood Test UK
Comprehensive gut biomarker panel, microbiome markers, leaky gut evidence
Inflammation Blood Test UK
hs-CRP, ESR, ferritin — systemic inflammation markers and what they reveal
Always Tired Blood Test UK
12 biomarkers behind persistent fatigue, NHS vs optimal ranges, 5 fatigue patterns
Medical disclaimer
This guide is for informational purposes only and does not constitute medical advice. Blood test results should be interpreted by a qualified healthcare professional in the context of your symptoms, medical history, and clinical examination. If you are experiencing any of the red-flag symptoms listed above, contact your GP or call NHS 111 without delay.
Reviewed by: PENDING — awaiting medical reviewer approval
Published: 2026-04-09 · Last updated: 2026-04-09